40.2 F
Indianapolis
Thursday, March 20, 2025

TAG

diabetes

Exposure: How COVID-19 Amplifies Healthcare Inequities in America

The third installment ofĀ "COVID and the Black Community," a weekly online community conversation series, co-hosted by New America and the Recorder, and featuring local...

Ask the IU Health Expert

What is stroke?Stroke is a disease that affects the blood vessels of the brain or spinal cord. The most common type of stroke is...

Black entrepreneurs address community health concerns with businesses that focus on wellness

Bad knees forced fitness enthusiast Kendra Blackett-Dibinga to quit her passion of running and training. But those same knee troubles ultimately lead her to...

On its 50th anniversary, more than 55 million Americans covered by Medicare

As Medicare and Medicaid celebrate their 50th anniversary protecting the health and well-being of millions of seniors, people with disabilities and low-income individuals,Ā the Centers...

Eating more blueberries, apples and pears linked to reduced risk of diabetes

Indianapolis, April 16, 2012 -- There is now even more reason to try fresh produce as recent research published in the American Journal of...

Marsh introduces ā€˜eat right live right with diabetes,ā€™

Indianapolis, April 3, 2012 ā€“ Marsh Supermarkets is recognizing National Public Health Week by introducing the first program of its kind in Indiana to...

Deliver us from diabetes

Diabetes is a disease that Nancy Dillon knows all too well.Ā  In her 20s, Dillon began caring for her father, who was diagnosed with...

Ask the Clarian Expert Diabetes

In recognition of November being American Diabetes Month, Dr. Carmella Evans-Molina will address your questions about diabetes. Dr. Evans-Molina is an endocrinologist with Clarian...

Aboriginal women suffer surge in diabetes

Native people, especially women, are developing the disease in their 40s - 30 years sooner than non-natives, study finds The rate of diabetes among...

Lilly licenses PDL type 1 diabetes drug candidate

PDL BioPharma Inc. said Monday that Eli Lilly & Co. is licensing its drug candidate teplizumab, an experimental treatment for newly diagnosed type 1...
- Advertisement -

Subscribe to our newsletter

To be updated with all the latest local news.

Stay connected

1FansLike
1FollowersFollow
1FollowersFollow
1SubscribersSubscribe

Latest news

- Advertisement -
EspaƱol + Translate Ā»
Skip to content